Updating neuropathology and neuropharmacology of monoaminergic systems

Rona R Ramsay; Philippe De Deurwaerdère; Giuseppe Di Giovanni

doi:10.1111/bph.13508

Updating neuropathology and neuropharmacology of monoaminergic systems

Br J Pharmacol. 2016 Jul;173(13):2065-8. doi: 10.1111/bph.13508.

Authors

Rona R Ramsay¹, Philippe De Deurwaerdère², Giuseppe Di Giovanni^{3

4}

Affiliations

¹ Biomedical Sciences Research Centre, University of St Andrews, St Andrews, UK.
² Institut of Neurodegenerative Disease, UMR CNRS 5293, Bordeaux cedex, France.
³ Neuroscience Division, School of Bioscience, Cardiff University, Cardiff, UK.
⁴ Department of Physiology and Biochemistry, University of Malta, Msida, Malta.

Abstract

This article is part of a themed section on Updating Neuropathology and Neuropharmacology of Monoaminergic Systems. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v173.13/issuetoc.

Publication types

Editorial
Introductory Journal Article

MeSH terms

Animals
Biogenic Monoamines / pharmacology*
Depression / drug therapy
Depression / metabolism
Depression / pathology
Diabetes Mellitus, Type 2 / drug therapy
Diabetes Mellitus, Type 2 / metabolism
Diabetes Mellitus, Type 2 / pathology
Humans
Mental Disorders / drug therapy
Mental Disorders / metabolism
Mental Disorders / pathology
Neuropharmacology*

Substances

Biogenic Monoamines